Sami Corwin
Stock Analyst at William Blair
(4.83)
# 442
Out of 4,673 analysts
428
Total ratings
59.7%
Success rate
20%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Initiated Coverage: Buy | n/a | $25.83 | - | 13 | Aug 20, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Hold | n/a | $66.70 | - | 14 | Aug 18, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $2.09 | - | 29 | Aug 13, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $3.13 | - | 28 | Aug 13, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | n/a | $8.42 | - | 13 | Aug 12, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $38.63 | - | 25 | Aug 11, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | n/a | $11.87 | - | 18 | Aug 6, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $9.30 | - | 20 | Aug 6, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | n/a | $0.6973 | - | 16 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $26.05 | - | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.50 | - | 20 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.76 | - | 30 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $346.58 | - | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $24.07 | -22.10% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.79 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.51 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $69.82 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $48.37 | - | 29 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $21.82 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.66 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.07 | - | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.00 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.09 | n/a | 4 | Feb 1, 2023 |
Ultragenyx Pharmaceutical
Aug 20, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $25.83
Upside: -
BioMarin Pharmaceutical
Aug 18, 2026
Maintained: Hold
Price Target: n/a
Current: $66.70
Upside: -
Allogene Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: n/a
Current: $2.09
Upside: -
Cabaletta Bio
Aug 13, 2026
Maintained: Buy
Price Target: n/a
Current: $3.13
Upside: -
Kyverna Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $8.42
Upside: -
Neurogene
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $38.63
Upside: -
Zevra Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $11.87
Upside: -
Solid Biosciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $9.30
Upside: -
Tenaya Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $0.6973
Upside: -
Tyra Biosciences
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.05
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $59.50
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.76
Upside: -
Aug 3, 2026
Maintained: Buy
Price Target: n/a
Current: $346.58
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $24.07
Upside: -22.10%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $18.79
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $3.51
Upside: -
Feb 20, 2026
Maintained: Buy
Price Target: n/a
Current: $69.82
Upside: -
Feb 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $48.37
Upside: -
Nov 12, 2025
Maintained: Hold
Price Target: n/a
Current: $21.82
Upside: -
Nov 11, 2025
Maintained: Hold
Price Target: n/a
Current: $2.66
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $2.07
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $17.00
Upside: n/a
Feb 1, 2023
Maintained: Buy
Price Target: n/a
Current: $6.09
Upside: n/a